- Home
- ALTO vs FHTX Comparison
ALTO vs FHTX Comparison
Compare ALTO & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | FHTX |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | United States |
| Employees | 390 | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.1M | 360.5M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALTO | FHTX |
|---|---|---|
| Price | $4.21 | $6.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | ★ 2.5M | 209.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | 25.32 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $917,927,000.00 | $30,909,000.00 |
| Revenue This Year | $6.66 | $8.89 |
| Revenue Next Year | $0.43 | $20.13 |
| P/E Ratio | $21.01 | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $0.92 | $3.27 |
| 52 Week High | $6.11 | $6.95 |
Technical Indicators
Market Signals| Indicator | ALTO | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.76 | 69.65 |
| Support Level | $2.35 | $4.37 |
| Resistance Level | $5.07 | $6.76 |
| Average True Range (ATR) | 0.34 | 0.37 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 12.96 | 84.96 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.